|
|
Volumn 11, Issue 6, 2010, Pages 521-523
|
|
A French approach to cost-effectiveness analysis?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATORVASTATIN;
ROSUVASTATIN;
SIMVASTATIN;
COST EFFECTIVENESS ANALYSIS;
ECONOMIC ASPECT;
EDITORIAL;
FRANCE;
HEALTH CARE COST;
HEALTH ECONOMICS;
HUMAN;
HYPERCHOLESTEROLEMIA;
PRIORITY JOURNAL;
QUALITY ADJUSTED LIFE YEAR;
REIMBURSEMENT;
CORONARY ARTERY DISEASE;
COST-BENEFIT ANALYSIS;
EFFICIENCY, ORGANIZATIONAL;
FRANCE;
HEALTH CARE COSTS;
HEALTH EXPENDITURES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
INSURANCE, HEALTH, REIMBURSEMENT;
|
|
EID: 78649904039
PISSN: 16187598
EISSN: None
Source Type: Journal
DOI: 10.1007/s10198-010-0284-9 Document Type: Editorial |
|
Times cited : (7)
|
|
References (3)
|
